Articles

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

Research and Medical Innovation Department, Centre Antoine Lacassagne, Nice, France
Division of Imaging, King’s College London, PET Centre, Guy’s & St. Thomas’ Hospital, London, UK
Nuclear Medicine Department, PET Center, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
Medical Physics Unit, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
Department of Radiology, Division of Nuclear Medicine, Mount Sinai Medical Center, New York, NY, USA
Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy
Nuclear Medicine Department, Centre Universitaire Hospitalier Henri Mondor, Creteril, Paris, France
Clinical Oncology Department. Guy’s & St. Thomas’ Hospital, London, UK
PET & Cyclotron Unit, Department of Clinical Physiology, Nuclear Medicine & PET, Rigshospitalet, Copenhagen University Hospital, Denmark
Department of Oncology, Gdynia Oncology Centre & Department of Propedeutic Oncology, University of Gdansk, Poland
Haematology Department, Peter MacCallum Cancer Centre, Melbourne, and University of Melbourne, Parkville Victoria, Australia
Center for Cancer Imaging Peter Mac Callum Cancer Center, Melbourne, Australia
Hematology Department, University of Florence, Careggi Hospital, Italy
Cellular Biotechnology and Hematology Department, Sapienza University, Rome, Italy
Hematology-Oncology Division, Center for Lymphoma & Myeloma, Weill Cornell Medical Center, New York, NY, USA
Department of Hematology & Bone Marrow Transplantation; Rambam Medical Center, Haifa, Israel
Hematology Department, University of Padua, Italy
Hematology Department, Hopital Le Bocage, Dijon, France
Hematology Department - Niguarda Ca’ Granda Hospital, Milan, Italy
Hematology Department Centre Hospitalier Universitaire St. Louis, Paris, France
Hematology Department, S. Gerardo University Hospital, Monza, Italy
Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Department of Hematology, SS Antonio e Biagio Hospital, Alessandria, Italy
Onco-Hematology Department, Modena University, Italy
Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Denmark
Vol. 99 No. 6 (2014): June, 2014 https://doi.org/10.3324/haematol.2013.103218